mogamulizumab: an exciting antibody for autoimmunity
Published 5 years ago • 156 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:12
mogamulizumab-associated rash in patients with ctcl
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
2:31
mavoric trial: mogamulizumab for r/r ctc
-
0:47
advice for physicians when managing bispecific antibody treatment for patients with myeloma
-
1:29
the current landscape of immunotherapy for aml: an update from ash 2023
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
1:10
canakinumab in preventing progression of high-risk ccus to myeloid neoplasms: a phase ii study
-
2:26
an insight into the aims of the eurasian hematology-oncology group
-
2:05
alnuctamab: improved route of administration and optimized dose level & dosing schedule
-
0:44
predictors of poor response to azacitidine, venetoclax, and magrolimab in tp53-mutated aml
-
1:59
the rapid evolution of myeloma research & the importance of improving drug accessibility
-
1:39
the mechanism of action of navtemadlin and its role in mf
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
1:52
an update on the use of navtemadlin in myelofibrosis
-
4:48
an insight into the management of cytopenias in mf